Society guideline links: Giant cell arteritis and polymyalgia rheumatica

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Vasculitis" and "Society guideline links: Takayasu arteritis".)

United States

●American College of Rheumatology (ACR)/Vasculitis Foundation (VF): Guideline for the management of giant cell arteritis and Takayasu arteritis (2021)

●European League Against Rheumatism (EULAR)/ACR: Recommendations for the management of polymyalgia rheumatica (2015)

Europe

●European League Against Rheumatism (EULAR): Recommendations for a core data set to support observational research and clinical care in giant cell arteritis, 2018 (published 2019)

●EULAR/American College of Rheumatology (ACR): Recommendations for the management of polymyalgia rheumatica (2015)

United Kingdom

●British Society for Rheumatology (BSR): Guideline on diagnosis and treatment of giant cell arteritis (2020)

●BSR and British Health Professionals in Rheumatology (BHPR): Guidelines for the management of polymyalgia rheumatica (2010)

●Royal College of Physicians (RCP): Concise guidance for diagnosis and management of giant cell arteritis (2010)

●RCP: Concise guidance for diagnosis and management of polymyalgia rheumatica (2010)